Status | Study |
Suspended |
Study Name: Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer Condition: Poorly Differentiated Thyroid Gland Carcinoma Recurrent Thyroid Gland Carcinoma Date: 2013-03-12 Interventions: Drug: Cabozantinib S-malate Gi |
Completed |
Study Name: Long-term Outcomes of Total Thyroidectomy Versus Less Than Total Thyroidectomy for Papillary Thyroid Microcarcinoma Condition: Papillary Thyroid Microcarcinoma Date: 2012-07-18 |
Completed |
Study Name: Genetic Expression Alteration Affect on Lateral Neck Node Metastasis of Thyroid Papillary Microcarcinoma : Microarray Analysis Condition: Papillary Thyroid Microcarcinoma Date: 2011-06-27 |
Recruiting |
Study Name: Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer Condition: Endometrial Cancer Date: 2011-05-26 Interventions: Drug: Carboplatin/Paclitaxel P |
Active, not recruiting |
Study Name: Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid Cancer Condition: Recurrent Thyroid Gland Carcinoma Stage I Thyroid Gland Follicular Carcinoma Date: 2010-09-22 Interventions: Drug: Cediranib Maleate Given |
Completed |
Study Name: Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients Condition: Thyroid Neoplasms Date: 2010-04-29 Interventions: Drug: Administration of 131 iodine 100 mCi 131 iodine irradiation |
Completed |
Study Name: Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid Condition: Papillary Thyroid Cancer Date: 2009-09-24 Interventions: Radiation: 99mTc-MIBI SPECT-CT 99mTc-MIBI SPECT-CT for abnormal cervical lymph node |
Completed |
Study Name: Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma Condition: Thyroid Cancer Date: 2008-11-19 Interventions: Procedure: Prophylactic central lymph node dissection prophylactic ipsilateral versus bilateral central |
Completed |
Study Name: Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy Condition: Recurrent Thyroid Gland Carcinoma Stage III Thyroid Gland Follicular Carcinoma Date: 2008-08-06 Interventions: Radiation: Fludeoxyglucose F-18 |
Completed |
Study Name: Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine Condition: Recurrent Thyroid Gland Carcinoma Stage I Thyroid Gland Papillary Carc Date: 2007-11-16 Interventions: Other: Laboratory Biomarker Analysis |